Filing Details
- Accession Number:
- 0001209191-22-051374
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-27 17:00:39
- Reporting Period:
- 2022-09-23
- Accepted Time:
- 2022-09-27 17:00:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1840574 | Verve Therapeutics Inc. | VERV | Pharmaceutical Preparations (2834) | 824800132 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1864116 | Andrew Bellinger | C/O Verve Therapeutics, Inc. 500 Technology Square, Suite 901 Cambridge MA 02139 | Cso & Cmo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-09-23 | 20,000 | $1.48 | 26,629 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-09-23 | 6,632 | $34.67 | 19,997 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-09-23 | 13,368 | $35.59 | 6,629 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-09-23 | 40,000 | $1.48 | 46,629 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-09-23 | 36,798 | $35.31 | 9,831 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-09-23 | 3,202 | $36.03 | 6,629 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2022-09-23 | 40,000 | $0.00 | 40,000 | $1.48 |
| Common Stock | Stock Option (right to buy) | Disposition | 2022-09-23 | 20,000 | $0.00 | 20,000 | $1.48 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 96,995 | 2029-09-16 | No | 4 | M | Direct | |
| 23,198 | 2029-09-16 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 17, 2022.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.24 to $35.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), and (5) of this Form 4.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.26 to $36.15, inclusive.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.90 to $35.88, inclusive.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.92 to $36.15, inclusive.
- The remaining shares underlying this option, which was granted on September 17, 2019, vest in equal monthly installments until October 1, 2023.
Billionaire Hedge Funds
